A 52-year-old man with a 10-year history of hypertension on amlodipine 5 mg daily presents with sudden-onset severe headache, chest pain, and dyspnea. His blood pressure is 210/140 mmHg. Physical examination reveals bilateral papilledema, retinal hemorrhages, and acute pulmonary edema on chest X-ray. Serum creatinine is 2.8 mg/dL (baseline 1.0 mg/dL), and urinalysis shows 3+ proteinuria with RBC casts. What is the most appropriate next step in management?

Explanation

## Recognition of Hypertensive Emergency **Key Point:** This patient has **hypertensive emergency** (not urgency) — defined by acute end-organ damage in the setting of severely elevated BP. The presence of papilledema, acute kidney injury, pulmonary edema, and hematuria with RBC casts indicates acute hypertensive nephrosclerosis and hypertensive encephalopathy. ## Pathophysiology of Hypertensive Emergency ```mermaid flowchart TD A[Severe HTN > 180/120]:::outcome --> B{End-organ damage?}:::decision B -->|Yes: Papilledema, AKI, PE, stroke| C[Hypertensive Emergency]:::urgent B -->|No: Headache, dyspnea alone| D[Hypertensive Urgency]:::outcome C --> E[Immediate IV therapy required]:::action E --> F[Target: Reduce MAP by 10-20% in 1 hour]:::action F --> G[Avoid rapid reduction > 25% in first hour]:::urgent D --> H[Oral agents, outpatient follow-up]:::action ``` **High-Yield:** The goal in hypertensive emergency is **controlled reduction**, not rapid normalization. Overly aggressive BP lowering risks stroke, MI, and acute coronary syndrome due to loss of cerebral autoregulation. ## Comparison of Antihypertensive Agents in Emergency | Agent | Onset | Duration | Titration | Best Use | Avoid | |-------|-------|----------|-----------|----------|-------| | **IV Labetalol** | 5–10 min | 3–6 hrs | Titrable in 10–20 mg increments | First-line for most emergencies | Asthma, bradycardia | | **IV Esmolol** | 1–2 min | 10–20 min | Rapid titration | Perioperative HTN | Decompensated HF | | **IV Nicardipine** | 5–10 min | 15–30 min | Smooth titration | Excellent safety profile | — | | **IV Hydralazine** | 10–20 min | 4–6 hrs | Unpredictable | Preeclampsia/eclampsia | Coronary artery disease | | **IV Nitroprusside** | < 1 min | 1–3 min | Rapid but uncontrolled | Last resort (cyanide toxicity risk) | Prolonged use (> 4 hrs) | | **Oral Nifedipine (immediate-release)** | 15–30 min | 4–6 hrs | Non-titrable, risk of stroke | **CONTRAINDICATED in emergency** | — | **Clinical Pearl:** Immediate-release nifedipine is **no longer recommended** for hypertensive emergencies because it is non-titrable and has caused strokes from unpredictable, precipitous BP drops. This is a common NEET PG trap. ## Why Labetalol is the Best Choice Here 1. **Predictable onset and duration** — allows careful titration 2. **Combined α and β blockade** — reduces BP without reflex tachycardia 3. **Safe in most end-organ damage scenarios** — including acute MI and pulmonary edema 4. **Target BP reduction:** 10–20% in first hour (160–180/100–110 mmHg), then slower reduction over 24 hours 5. **No risk of cyanide toxicity** (unlike nitroprusside) **Mnemonic — IV Agents in HTN Emergency:** **LEND** = Labetalol (first-line), Esmolol (perioperative), Nicardipine (smooth), Diuretics (for pulmonary edema). ## Why Each Distractor is Wrong **Oral nifedipine:** Non-titrable, unpredictable absorption, risk of stroke from sudden uncontrolled drop. Contraindicated in emergency. **Nitroprusside with 50% reduction in 15 min:** Excessive speed of BP reduction risks stroke, MI, and acute coronary syndrome. Also risk of cyanide toxicity with prolonged use. **Hydralazine:** Unpredictable onset (10–20 min) and duration; not suitable for titration. Preferred for preeclampsia/eclampsia, not general hypertensive emergency. [cite:Harrison 21e Ch 297]